Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “XTL BIOPHARMACEUTICALS LTD.”

7 pharma patents match "XTL BIOPHARMACEUTICALS LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 7
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 7 pharmaceutical patents matching "XTL BIOPHARMACEUTICALS LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

7 results for “XTL BIOPHARMACEUTICALS LTD.” · 30,257 patents in full index Clear search

  1. US 8329703

    Pyrazole compounds

    XTL BIOPHARMACEUTICALS LTD. · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  2. US 8143276

    4-thio substituted quinoline and naphthyridine compounds

    XTL BIOPHARMACEUTICALS LTD. · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  3. US 8048889

    3,4-disubstituted coumarin and quinolone compounds

    XTL BIOPHARMACEUTICALS LTD. · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  4. US 7994360

    Benzofuran compounds

    XTL BIOPHARMACEUTICALS LTD. · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted
  5. US 7923004

    4-ethynyl pyrazole derivative compounds and methods for treatment of HCV

    XTL BIOPHARMACEUTICALS LTD. · Granted Apr 12, 2011 · Expires Apr 7, 2031

    granted
  6. US 6254867

    Human monoclonal antibodies to the hepatitis B surface antigen

    XTL BIOPHARMACEUTICALS LTD. · Granted Jul 3, 2001 · Expires Jun 28, 2021

    expired
  7. US 6146629

    Human monoclonal antibody against Hepatitis B virus surface antigen (HBVsAg)

    XTL BIOPHARMACEUTICALS LTD. · Granted Nov 14, 2000 · Expires Nov 9, 2020

    expired